Skip to content

Elevance Health ELV Additional Paid-In Capital

Additional Paid-In Capital at other companies

Humana logo
HumanaHUM
$3.64B+4.1%
UnitedHealth Group logo
UnitedHealth GroupUNH
$556M
Centene logo
CenteneCNC
$20.82B+0.9%
Molina Healthcare logo
Molina HealthcareMOH
$471M+8.5%
Oscar Health logo
Oscar HealthOSCR
$4.28B+9.6%
Alignment Healthcare logo
Alignment HealthcareALHC
$1.2B+7.0%

Other financials

Income statement

See full
Revenue$50.2B+2.6%
Gross profit$44.7B+1.8%
Net income$1.8B-19.2%
EPS (diluted)$8.00-16.8%

Balance sheet

See full
Cash & equivalents$9.7B+28.8%
Total debt$31.5B+11.0%
Total equity$43.9B+3.3%
Total assets$125.83B+5.1%

Cash flow

See full
Operating cash flow$4.3B+326%
CapEx$235.0M+19.9%
Free cash flow$4.1B+399%

Valuation

See full
Market cap$83.98B+7.6%
Enterprise value$105.82B+8.0%
P/E16×+1.5×
P/S0.4×0.0×

Profitability

See full
Gross margin89.2%+0.6pp
Net margin2.6%-0.6pp
FCF margin3.3%+1.3pp

Returns & leverage

See full
Return on equity12.1%-2.1pp
Debt / equity0.7×+0.1×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Elevance Health in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Elevance Health’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Elevance Health's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Elevance Health's additional paid-in capital?
Elevance Health (ELV) reported additional paid-in capital of $8.85B in Q1 2026.
How has Elevance Health's additional paid-in capital changed year-over-year?
Elevance Health's additional paid-in capital decreased by 0.2% year-over-year, from $8.87B to $8.85B.
What is the long-term trend for Elevance Health's additional paid-in capital?
Over 5 years (2020 to 2025), Elevance Health's additional paid-in capital has grown at a -0.7% compound annual growth rate (CAGR), from $9.24B to $8.94B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.